Projects funded by the NCN
The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF inhibitors in malignant melanoma therapy
2018/31/N/NZ5/03561
Keywords:
6-phosphofructo-20kinase/fructose-2,6-bisphosphatase malignant melanoma glucose metabolism BRAF inhibitors
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 16 - announced on 2018-09-14
Amount awarded: 209 929 PLN
Project start date (Y-m-d): 2019-08-01
Project end date (Y-m-d): 2024-07-31
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.